Waiting for in-Lab Polysomnography May Unnecessarily Prolong Treatment Start in Patients with Moderate or Severe OSA at Home Sleep Apnea Testing
Open Access
- 1 December 2024
- journal article
- research article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 16, 1881-1889
Abstract
Purpose: The gold standard in obstructive sleep apnea (OSA) diagnostics is nocturnal full-night polysomnography (PSG). Due to high costs and high time effort portable respiratory polygraphy (PG or home sleep apnea testing-HSAT) has been developed. In contrast to PG the PSG gains relevant further information concerning sleep stages, arousals and leg movements. However, the role of PG in the diagnostic of OSA remains largely undefined. The aim of this study was to investigate the difference of PG- and PSG- related metrics in OSA, to understand if there is a difference in PG and PSG-based treatment decision and show up the time between performed PG and PSG. Patients and Methods: 99 consecutive patients with existing outpatient performed PG and followed PSG in our tertiary care otorhinolaryngology department between February 2020 and December 2023 were retrospectively assessed. All patients were treatment-naive at the time of consultation. The time between performed outpatient PG and PSG was calculated. Furthermore, clinical baseline parameter and PG as well as PSG data were evaluated. All data were then blinded presented with relevant comorbid diseases to two experts in sleep medicine in our tertiary care centre to decide whether PAP therapy was indicated or not. Results: Mean AHI was significantly higher in PSG (32.32 ± 22.78/h) compared to PG (22.60 ± 15.12/h) (p< 0.001). Mean duration between performed PG and PSG was 194.99 ± 131.96 days (range between 37 and 842 days). Only in two patients PAP-therapy was indicated with PG results but not with PSG results. Only in one case PAP-therapy was not indicated with PG results but with PSG results. Conclusion: These data suggest initiating OSA therapy based on PG results for patients with at least moderate OSA on PG, followed by a confirming PSG and a control PSG under treatment to avoid unnecessary prolongation of treatment start.Keywords
This publication has 26 references indexed in Scilit:
- Teil-Aktualisierung S3-Leitlinie Schlafbezogene Atmungsstörungen bei ErwachsenenSomnologie, 2020
- Diagnosis and Management of Obstructive Sleep ApneaJAMA, 2020
- Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysisThe Lancet Respiratory Medicine, 2019
- Do T90 and SaO2 nadir identify a different phenotype in obstructive sleep apnea?Sleep and Breathing, 2019
- Diagnostische Genauigkeit ambulanter PolygraphiegeräteHNO, 2017
- Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysisThe Lancet Respiratory Medicine, 2015
- Évaluation d’un système de polygraphie ventilatoire dans le syndrome d’apnées du sommeilRevue des Maladies Respiratoires, 2007
- Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/HypopneaArchives of internal medicine (1960), 2006
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Validation of a Respiratory Polygraphy System in the Diagnosis of Sleep Apnea SyndromeArchivos de Bronconeumología, 2005